Search Results - Christine E. Sheehan
- Showing 1 - 16 results of 16
-
1
-
2
-
3
Vascular Targeted Therapy With Anti–Prostate-Specific Membrane Antigen Monoclonal Antibody J591 in Advanced Solid Tumors by Matthew I. Milowsky, David M. Nanus, Lale Kostakoğlu, Christine E. Sheehan, Shankar Vallabhajosula, Stanley J. Goldsmith, Jeffrey S. Ross, Neil H. Bander
Published 2007Artigo -
4
-
5
Prognostic significance of HER-2/neu gene amplification status by fluorescence in Situ hybridization of prostate carcinoma by Jeffrey S. Ross, Christine E. Sheehan, Alida Hayner‐Buchan, Robert A. Ambros, Bhaskar Kallakury, Ronald P. Kaufman, Hugh A.�G. Fisher, Matthew D. Rifkin, Patrick Muraca
Published 1997Artigo -
6
Genomic Profiling of Advanced-Stage, Metaplastic Breast Carcinoma by Next-Generation Sequencing Reveals Frequent, Targetable Genomic Abnormalities and Potential New Treatment Optio... by Jeffrey S. Ross, Sunil Badve, Kai Wang, Christine E. Sheehan, Ann Boguniewicz, Geoff Otto, Roman Yelensky, Doron Lipson, Siraj M. Ali, Deborah Morosini, Juliann Chliemlecki, Julia A. Elvin, Vincent A. Miller, Philip J. Stephens
Published 2015Artigo -
7
Randomized phase II study of weekly docetaxel plus trastuzumab versus weekly paclitaxel plus trastuzumab in patients with previously untreated advanced nonsmall cell lung carcinoma by Lee M. Krug, Vincent A. Miller, Jyoti D. Patel, John P. Crapanzano, Christopher G. Azzoli, Jorge Gómez, Mark G. Kris, Robert T. Heelan, Barbara Pizzo, Leslie B. Tyson, Christine E. Sheehan, Jeffrey S. Ross, Ennapadam Venkatraman
Published 2005Artigo -
8
The significance of TNFAIP8 in prostate cancer response to radiation and docetaxel and disease recurrence by Chuanbo Zhang, Bhaskar Kallakury, Jeffrey S. Ross, Rajshree Mewani, Christine E. Sheehan, Isamu Sakabe, George Luta, Deepak Kumar, Sivaramakrishna Yadavalli, Joshua Starr, Taduru Sreenath, Shiv Srivastava, Harvey B. Pollard, Ofer Eidelman, Meera Srivastava, Usha N. Kasid
Published 2012Artigo -
9
Relapsed Classic E-Cadherin (<i>CDH1</i>)–Mutated Invasive Lobular Breast Cancer Shows a High Frequency of<i>HER2</i>(<i>ERBB2</i>) Gene Mutations by Jeffrey S. Ross, Kai Wang, Christine E. Sheehan, Ann Boguniewicz, Geoff Otto, Sean R. Downing, James Sun, Jie He, John A. Curran, Siraj M. Ali, Roman Yelensky, Doron Lipson, Gary A. Palmer, Vincent A. Miller, Philip J. Stephens
Published 2013Artigo -
10
Next-generation sequencing reveals frequent consistent genomic alterations in small cell undifferentiated lung cancer by Jeffrey S. Ross, K Wang, Osama Elkadi, Ashley J. Tarasen, Llewelyn Foulke, Christine E. Sheehan, Geoff Otto, Gary A. Palmer, Roman Yelensky, Doron Lipson, Juliann Chmielecki, Siraj M. Ali, Julia A. Elvin, Deborah Morosini, V.A. Miller, Philip J. Stephens
Published 2014Artigo -
11
Next-generation sequencing of adrenocortical carcinoma reveals new routes to targeted therapies by Jeffrey S. Ross, K Wang, Janne V. Rand, Laurie M. Gay, Marco Presta, Christine E. Sheehan, Siraj M. Ali, Julia A. Elvin, Elaine LaBrecque, Christine N. Hiemstra, Jamie Buell, Geoffrey A. Otto, Roman Yelensky, Doron Lipson, Deborah Morosini, Juliann Chmielecki, V.A. Miller, Phil Stephens
Published 2014Artigo -
12
Advanced urothelial carcinoma: next-generation sequencing reveals diverse genomic alterations and targets of therapy by Jeffrey S. Ross, Kai Wang, Rami N. Al‐Rohil, Tipu Nazeer, Christine E. Sheehan, Geoff Otto, Jie He, Gary A. Palmer, Roman Yelensky, Doron Lipson, Siraj M. Ali, Sohail Balasubramanian, John A. Curran, Lazlo Garcia, Kristen Mahoney, Sean R. Downing, Matthew Hawryluk, Vincent A. Miller, Philip J. Stephens
Published 2013Artigo -
13
New Routes to Targeted Therapy of Intrahepatic Cholangiocarcinomas Revealed by Next-Generation Sequencing by Jeffrey S. Ross, Kai Wang, Laurie M. Gay, Rami N. Al‐Rohil, Janne V. Rand, David Jones, Hwa J. Lee, Christine E. Sheehan, Geoff Otto, Gary A. Palmer, Roman Yelensky, Doron Lipson, Deborah Morosini, Matthew Hawryluk, Daniel V.T. Catenacci, Vincent A. Miller, Chaitanya Churi, Siraj M. Ali, Philip J. Stephens
Published 2014Artigo -
14
<i>ALK</i>Fusions in a Wide Variety of Tumor Types Respond to Anti-ALK Targeted Therapy by Jeffrey S. Ross, Siraj M. Ali, Omotayo Fasan, Jared Block, Sumanta K. Pal, Julia A. Elvin, Alexa B. Schrock, James Suh, Sahar Nozad, Sungeun Kim, Hwajeong Lee, Christine E. Sheehan, David Jones, Jo‐Anne Vergilio, Shakti Ramkissoon, Eric A. Severson, Sugganth Daniel, David Fabrizio, Garrett M. Frampton, V. A. Miller, Philip J. Stephens, Laurie M. Gay
Published 2017Artigo -
15
A High Frequency of Activating Extracellular Domain <i>ERBB2</i> (<i>HER2</i>) Mutation in Micropapillary Urothelial Carcinoma by Jeffrey S. Ross, Kai Wang, Laurie M. Gay, Rami N. Al‐Rohil, Tipu Nazeer, Christine E. Sheehan, Timothy A. Jennings, Geoff Otto, Amy Donahue, Jie He, Gary A. Palmer, Siraj M. Ali, Michelle Nahas, Geneva Young, Elaine LaBrecque, Garrett M. Frampton, Rachel Erlich, John A. Curran, Kristina Brennan, Sean R. Downing, Roman Yelensky, Doron Lipson, Matthew Hawryluk, Vincent A. Miller, Philip J. Stephens
Published 2013Artigo -
16
Identification of new ALK and RET gene fusions from colorectal and lung cancer biopsies by Doron Lipson, Marzia Capelletti, Roman Yelensky, Geoff Otto, Alex Parker, Mirna Jarosz, John A. Curran, Sohail Balasubramanian, Troy Bloom, Kristina Brennan, Amy Donahue, Sean R. Downing, Garrett M. Frampton, Lázaro Ibrahim Romero García, Frank Juhn, Kathy C Mitchell, Emily White, Jared White, Zac Zwirko, Tamar Peretz, Hovav Nechushtan, Lior Soussan‐Gutman, Young Tae Kim, Hidefumi Sasaki, Hyeong Ryul Kim, Seung-Il Park, Dalia Ercan, Christine E. Sheehan, Jeffrey S. Ross, Maureen Cronin, Pasi A. Jänne, Philip J. Stephens
Published 2012Artigo
Search Tools:
Related Subjects
Medicine
Cancer
Biology
Cancer research
Internal medicine
Genetics
Gene
Oncology
Pathology
Colorectal cancer
Exon
KRAS
Apoptosis
CDKN2A
Immunohistochemistry
Lung cancer
PI3K/AKT/mTOR pathway
PTEN
Breast cancer
Carcinoma
Fusion gene
HRAS
Mutation
Prostate cancer
Targeted therapy
ARID1A
Adenocarcinoma
Antibody
Bioinformatics
Chromosome